Articles

Inferior survival in high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements is not associated with MYC/IG gene rearrangements

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
Department of Hematology and Oncology, Wake Forest Baptist Health, Winston-Salem, NC
Department of Health Sciences Research, Mayo Clinic, Rochester, MN
Division of Hematology, Mayo Clinic, Rochester, MN, USA
Division of Hematology, Mayo Clinic, Rochester, MN, USA
Division of Hematology, Mayo Clinic, Rochester, MN, USA
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN;Division of Hematology, Mayo Clinic, Rochester, MN, USA
Division of Hematology, Mayo Clinic, Rochester, MN, USA
Vol. 103 No. 11 (2018): November, 2018 https://doi.org/10.3324/haematol.2018.190157